Effect of history of tuberculosis on specificity of Xpert MTB/RIF

Frederick Haraka, Samuel G. Schumacher, Amanda Ross, Anna Mantsoki, Sebastien Gagneux, Klaus Reither, Claudia M. Denkinger

Source: Eur Respir J, 56 (3) 2000343; 10.1183/13993003.00343-2020
Journal Issue: September
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Frederick Haraka, Samuel G. Schumacher, Amanda Ross, Anna Mantsoki, Sebastien Gagneux, Klaus Reither, Claudia M. Denkinger. Effect of history of tuberculosis on specificity of Xpert MTB/RIF. Eur Respir J, 56 (3) 2000343; 10.1183/13993003.00343-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Early tuberculosis treatment monitoring by Xpert® MTB/RIF
Source: Eur Respir J 2012; 39: 1269-1271
Year: 2012


Incremental Yield of Xpert MTB/RIF Ultra over Xpert MTB/RIF in the diagnosis of extra-pulmonary tuberculosis
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020


Utility of Xpert® MTB/RIF assay for extrapulmonary tuberculosis, a two year study
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019


Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
Source: Eur Respir J 2012; 40: 442-447
Year: 2012



Sensitivity of Xpert MTB/RIF in induced sputum in smear negative pulmonary tuberculosis patients?
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017

Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis
Source: Eur Respir J 2013; 42: 708-720
Year: 2013



Performance of Xpert MTB/RIF Ultra for tuberculosis diagnosis in the context of passive and active case finding
Source: Eur Respir J, 58 (6) 2100257; 10.1183/13993003.00257-2021
Year: 2021



The yield of bronchoscopy in sputum Xpert MTB/Rif negative tuberculosis in the Xpert era.
Source: Virtual Congress 2020 – Diagnostic challenges in tuberculosis
Year: 2020


Clinical utility of the Xpert MTB/RIF test in induced sputum
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


Rapid diagnosis of tuberculosis and rifampin resistance by GeneXpert MTB/RIF test
Source: International Congress 2018 – Diagnosis of tuberculosis
Year: 2018

A sputum sample processing method for community and mobile tuberculosis diagnosis using the Xpert MTB/RIF assay
Source: ERJ Open Res, 5 (1) 00165-2018; 10.1183/23120541.00165-2018
Year: 2019



Xpert MTB/RIF assay for rapid detection of Mycobacterium tuberculosis and rifampicin resistance
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012

Do adjunct tuberculosis tests, when combined with Xpert MTB/RIF, improve accuracy and the cost of diagnosis in a resource-poor setting?
Source: Eur Respir J 2012; 40: 161-168
Year: 2012



Xpert MTB/RIF testing of pooled induced sputum
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014

Is Xpert MTB/Rif Ultra superior to Xpert MTB/Rif for the diagnosis of tuberculosis in children in Uzbekistan
Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function
Year: 2021

Xpert MTB/RIF as add-on test to microscopy in a low tuberculosis incidence setting
Source: Eur Respir J, 51 (3) 1702345; 10.1183/13993003.02345-2017
Year: 2018



How is Xpert MTB/RIF being implemented in 22 high tuberculosis burden countries?
Source: Eur Respir J 2015; 45: 549-554
Year: 2015


A comparison between the efficiency of the Xpert MTB/RIF assay and nested PCR in identifying mycobacterium tuberculosis during routine clinical practice
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014

Suboptimal specificity of Xpert MTB/RIF among treatment-experienced patients
Source: Eur Respir J 2015; 45: 1504-1506
Year: 2015


Determining the role of Xpert® MTB/RIF in diagnosing tuberculosis in postmortem tissues
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015